The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Bisphosphonate Drug Market Research Report 2024
Synopsis
Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
The global Bisphosphonate Drug market was valued at US$ 854 million in 2023 and is anticipated to reach US$ 1241.1 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bisphosphonate Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bisphosphonate Drug.
Report Scope
The Bisphosphonate Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bisphosphonate Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bisphosphonate Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Segment by Type
Alendronate
Risedronate
Zoledronic Acid
Other Bisphosphonate Drug
Segment by Application
Postmenopausal Osteoporosis
Men with Osteoporosis
Paget’s Disease
Bone Loss Caused by Cancer Treatment
Osteoporosis Imperfecta in Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bisphosphonate Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bisphosphonate Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Bisphosphonates are drugs that inhibit mineralization or resorption of the bone by blocking the action of osteoclasts. Bisphosphonates are enzyme-resistant analogues of pyrophosphate, which normally inhibits mineralization in the bone. Their effect is dose dependent and they reduce the turnover of bone by inhibiting recruitment and promoting apoptosis of osteoclasts. Bisphosphonates are used to treat postmenopausal and glucocorticoid induced osteoporosis, Paget's disease of bone and malignant hypercalcemia.
The global Bisphosphonate Drug market was valued at US$ 854 million in 2023 and is anticipated to reach US$ 1241.1 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bisphosphonate Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bisphosphonate Drug.
Report Scope
The Bisphosphonate Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bisphosphonate Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bisphosphonate Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Teva
Mylan
Apotex Corp
Cobalt Pharmaceuticals
Genentech
Novartis Pharmaceuticals
Sanofi-Aventis
Segment by Type
Alendronate
Risedronate
Zoledronic Acid
Other Bisphosphonate Drug
Segment by Application
Postmenopausal Osteoporosis
Men with Osteoporosis
Paget’s Disease
Bone Loss Caused by Cancer Treatment
Osteoporosis Imperfecta in Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bisphosphonate Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bisphosphonate Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Bisphosphonate Drug Market Overview
1.1 Product Overview and Scope of Bisphosphonate Drug
1.2 Bisphosphonate Drug Segment by Type
1.2.1 Global Bisphosphonate Drug Market Value Comparison by Type (2024-2030)
1.2.2 Alendronate
1.2.3 Risedronate
1.2.4 Zoledronic Acid
1.2.5 Other Bisphosphonate Drug
1.3 Bisphosphonate Drug Segment by Application
1.3.1 Global Bisphosphonate Drug Market Value by Application: (2024-2030)
1.3.2 Postmenopausal Osteoporosis
1.3.3 Men with Osteoporosis
1.3.4 Paget’s Disease
1.3.5 Bone Loss Caused by Cancer Treatment
1.3.6 Osteoporosis Imperfecta in Children
1.4 Global Bisphosphonate Drug Market Size Estimates and Forecasts
1.4.1 Global Bisphosphonate Drug Revenue 2019-2030
1.4.2 Global Bisphosphonate Drug Sales 2019-2030
1.4.3 Global Bisphosphonate Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bisphosphonate Drug Market Competition by Manufacturers
2.1 Global Bisphosphonate Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bisphosphonate Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bisphosphonate Drug Average Price by Manufacturers (2019-2024)
2.4 Global Bisphosphonate Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bisphosphonate Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bisphosphonate Drug, Product Type & Application
2.7 Bisphosphonate Drug Market Competitive Situation and Trends
2.7.1 Bisphosphonate Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bisphosphonate Drug Players Market Share by Revenue
2.7.3 Global Bisphosphonate Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bisphosphonate Drug Retrospective Market Scenario by Region
3.1 Global Bisphosphonate Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bisphosphonate Drug Global Bisphosphonate Drug Sales by Region: 2019-2030
3.2.1 Global Bisphosphonate Drug Sales by Region: 2019-2024
3.2.2 Global Bisphosphonate Drug Sales by Region: 2025-2030
3.3 Global Bisphosphonate Drug Global Bisphosphonate Drug Revenue by Region: 2019-2030
3.3.1 Global Bisphosphonate Drug Revenue by Region: 2019-2024
3.3.2 Global Bisphosphonate Drug Revenue by Region: 2025-2030
3.4 North America Bisphosphonate Drug Market Facts & Figures by Country
3.4.1 North America Bisphosphonate Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bisphosphonate Drug Sales by Country (2019-2030)
3.4.3 North America Bisphosphonate Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bisphosphonate Drug Market Facts & Figures by Country
3.5.1 Europe Bisphosphonate Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bisphosphonate Drug Sales by Country (2019-2030)
3.5.3 Europe Bisphosphonate Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bisphosphonate Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Bisphosphonate Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bisphosphonate Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Bisphosphonate Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bisphosphonate Drug Market Facts & Figures by Country
3.7.1 Latin America Bisphosphonate Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bisphosphonate Drug Sales by Country (2019-2030)
3.7.3 Latin America Bisphosphonate Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bisphosphonate Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Bisphosphonate Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bisphosphonate Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bisphosphonate Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bisphosphonate Drug Sales by Type (2019-2030)
4.1.1 Global Bisphosphonate Drug Sales by Type (2019-2024)
4.1.2 Global Bisphosphonate Drug Sales by Type (2025-2030)
4.1.3 Global Bisphosphonate Drug Sales Market Share by Type (2019-2030)
4.2 Global Bisphosphonate Drug Revenue by Type (2019-2030)
4.2.1 Global Bisphosphonate Drug Revenue by Type (2019-2024)
4.2.2 Global Bisphosphonate Drug Revenue by Type (2025-2030)
4.2.3 Global Bisphosphonate Drug Revenue Market Share by Type (2019-2030)
4.3 Global Bisphosphonate Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bisphosphonate Drug Sales by Application (2019-2030)
5.1.1 Global Bisphosphonate Drug Sales by Application (2019-2024)
5.1.2 Global Bisphosphonate Drug Sales by Application (2025-2030)
5.1.3 Global Bisphosphonate Drug Sales Market Share by Application (2019-2030)
5.2 Global Bisphosphonate Drug Revenue by Application (2019-2030)
5.2.1 Global Bisphosphonate Drug Revenue by Application (2019-2024)
5.2.2 Global Bisphosphonate Drug Revenue by Application (2025-2030)
5.2.3 Global Bisphosphonate Drug Revenue Market Share by Application (2019-2030)
5.3 Global Bisphosphonate Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Bisphosphonate Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Bisphosphonate Drug Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Bisphosphonate Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Bisphosphonate Drug Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Bisphosphonate Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Bisphosphonate Drug Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Apotex Corp
6.4.1 Apotex Corp Corporation Information
6.4.2 Apotex Corp Description and Business Overview
6.4.3 Apotex Corp Bisphosphonate Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Corp Bisphosphonate Drug Product Portfolio
6.4.5 Apotex Corp Recent Developments/Updates
6.5 Cobalt Pharmaceuticals
6.5.1 Cobalt Pharmaceuticals Corporation Information
6.5.2 Cobalt Pharmaceuticals Description and Business Overview
6.5.3 Cobalt Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cobalt Pharmaceuticals Bisphosphonate Drug Product Portfolio
6.5.5 Cobalt Pharmaceuticals Recent Developments/Updates
6.6 Genentech
6.6.1 Genentech Corporation Information
6.6.2 Genentech Description and Business Overview
6.6.3 Genentech Bisphosphonate Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Genentech Bisphosphonate Drug Product Portfolio
6.6.5 Genentech Recent Developments/Updates
6.7 Novartis Pharmaceuticals
6.6.1 Novartis Pharmaceuticals Corporation Information
6.6.2 Novartis Pharmaceuticals Description and Business Overview
6.6.3 Novartis Pharmaceuticals Bisphosphonate Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Pharmaceuticals Bisphosphonate Drug Product Portfolio
6.7.5 Novartis Pharmaceuticals Recent Developments/Updates
6.8 Sanofi-Aventis
6.8.1 Sanofi-Aventis Corporation Information
6.8.2 Sanofi-Aventis Description and Business Overview
6.8.3 Sanofi-Aventis Bisphosphonate Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi-Aventis Bisphosphonate Drug Product Portfolio
6.8.5 Sanofi-Aventis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bisphosphonate Drug Industry Chain Analysis
7.2 Bisphosphonate Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bisphosphonate Drug Production Mode & Process
7.4 Bisphosphonate Drug Sales and Marketing
7.4.1 Bisphosphonate Drug Sales Channels
7.4.2 Bisphosphonate Drug Distributors
7.5 Bisphosphonate Drug Customers
8 Bisphosphonate Drug Market Dynamics
8.1 Bisphosphonate Drug Industry Trends
8.2 Bisphosphonate Drug Market Drivers
8.3 Bisphosphonate Drug Market Challenges
8.4 Bisphosphonate Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
